Reduced levels of serum 25(OH)D3 are associated with tuberculosis positive cattle under conditions of high natural exposure to Mycobacterium bovis

https://doi.org/10.1016/j.cimid.2022.101746Get rights and content

Highlights

  • Reduced levels of serum 25(OH)D3 are associated to bovine TB.

  • Reduced levels of serum 25(OH)D3 are associated to low mycobactericidal capacity in bovine macrophages model.

  • Levels of serum > 80 ng / mL 25 (OH) D3 are necessary to counteract infection by M. bovis.

Abstract

Serum vitamin D (25(OH)D3) concentrations of < 30 ng/mL in cattle are insufficient to induce an adequate immune response against intracellular pathogens, which suggests that the efficacy of the immune response may be highly dependent on the bioavailability of 25(OH)D3. This study shows an overview of both in vitro and in vivo 25(OH)D3-mediated immune modulation amongst dairy cattle naturally exposed to M. bovis. Tuberculin status was confirmed by interferon gamma release assay (IGRA), and natural exposure was demonstrated by polymerase chain reaction (PCR). Tuberculin (-) cattle have a higher serum concentration of 25(OH)D3 (X¯= 87.12 ng/mL) when compared to tuberculin (+) cattle (X¯ = 45.86 ng/mL). Reduced serum 25(OH)D3 levels are associated with the presence of bovine TB, and serum 25(OH)D3 levels of > 80 ng/mL are necessary to counteract infection by M. bovis. Kill assays were performed to evaluate in vitro 25(OH)D3 modulation of intracellular M. bovis growth in bovine macrophages, which showed that reduced serum 25(OH)D3 levels are associated with diminished mycobactericidal capacity in this experimental model. On the other hand, increased 25(OH)D3 in culture media enhances phagocytosis and nitric oxide production, which in turn improves capacity to combat M. bovis.

Introduction

Tuberculosis is one of the most studied infectious diseases in the world. However, certain aspects of the disease are still not fully understood [1], [2]. Mycobacterium bovis is an important pathogen belonging to the M. tuberculosis complex (MTBC), which affects a wide variety of both wild and domesticated hosts. As the causative agent of bovine tuberculosis (bTB), M. bovis unquestionably has worldwide zoonotic potential and represents a serious threat to animal and human health. bTB is present mainly in developing countries, causing considerable economic losses and restrictions on beef/cattle commercialization [3]. None of the existing official control and prevention policies focus on bolstering affected animals' immune response to M. bovis [4], [5].

Calcitriol (1,25(OH)2D3), the bioactivated form of vitamin D3, in addition to its well-known role in calcium and phosphorus homeostasis [6], is a powerful immunomodulator. It is a fat-soluble hormone derived from cholesterol whose main source is the photochemical conversion of 7-dihydrocholesterol to vitamin D3 (cholecalciferol) in the skin through exposure to UV rays; it is then hydroxylated twice- first in the liver, where it is converted to 25(OH)D3, and subsequently in the kidneys to produce calcitriol [7]. Immune system cells express the genetic codes for 25-hydroxyvitamin D3 1α-hydroxylase (CYP27B1), which then allows for intracrine calcitriol synthesis with two essentially opposing effects: while in innate immunity calcitriol participates in macrophage activation and subsequently more efficient microbicidal function [8], [9], [10], [11], [12], in the adaptive immune response it acts on lymphocytes, down-regulating interferon gamma (IFN-γ) production in chronic inflammation [13], [14].

1,25(OH)2D3 has long been associated with resistance and immunity to tuberculosis [15], [16], [17], [18], and its role in controlling mycobacterial infection has been proven in recent years. In cattle experimentally infected with M. bovis, a rapid increase in serum calcitriol concentration is observed, along with heightened intracellular calcitriol production in mononuclear cells present in lymph nodes and within the granuloma itself [19]. Macrophages are the main actors involved in the immune response against M. bovis infection, and their mycobactericidal activity depends on the vitamin D signaling pathway [20], [21], [22], [23]. Macrophages stimulated with 25(OH)D3 and IFN-γ have been shown to reduce intracellular growth of M. tuberculosis by 60% [24]. In addition, recognition of PAMP by macrophages is necessary to activate CYP27B1 expression and the signaling pathway from the vitamin D receptor (VDR), with the subsequent expression of genes related to the production of antimicrobial molecules [22], [25], [26] and an increased amount of cathelicidins, beta defensins, and nitric oxide (NO) [27], [28], [29]. The intracellular production of NO in the bovine macrophage, which has been proposed as a tuberculosis-resistant mechanism, is also dependent on calcitriol [30], [31], [32].

Bioavailability of 25(OH)D3 must therefore play an important role in defense against tuberculosis infection. Reduced levels of serum 25(OH)D3 (<30 ng/mL) delay cell differentiation, phagosome maturation, and phagolysosomal fusion, resulting in poor control of the bacteria [12], [33], [34], [35], [36], [37], [38]. The role of vitamin D3 in the immune response to tuberculosis has been documented via the phenomenon of racial predisposition to the disease. African Americans are more susceptible to clinical illness when infected with tuberculosis, which parallels lower serum 25(OH)D3 levels. Mycobacterium elimination becomes more efficient in human macrophages derived from peripheral blood mononuclear cells (PMBC) infected with M. tuberculosis and cultured with serum from Caucasians with 25(OH)D3 concentrations > 28 ng/mL, associated with an increase in cathelicidin mRNA expression (LL37). On the other hand, when monocytes are cultured with serum from African Americans (<10 ng/mL of 25(OH)D3), cathelicidin expression decreases, favoring mycobacterial survival. Interestingly, the microbicidal activity of macrophages is re-established when they are cultured with serum supplemented with 40 ng/mL of 25(OH)D3 [35].

A similar situation occurs with other mycobacteria. For example, a dairy herd with natural exposure to M. avium subsp paratuberculosis (MAP) presented an average blood 25(OH)D3 concentration of 62.5 ng/mL. Animals that were serology positive for MAP had a lower concentration (5.3 ng/mL) of 25(OH)D3 when compared to MAP-negative individuals [39]. The effect of paratuberculosis infection on serum 25(OH)D3 concentration has also been evaluated, with clinically ill cows presenting a significantly lower 25(OH)D3 concentration (58.8 ng/mL) than either subclinical (97 ng/mL) or uninfected cows (84 ng/mL). Thus, serum 25(OH)D3 concentration is linked to the ability of animals to fight infection [40]. In general, it has been observed that immune system cells are potentially susceptible to changes in serum 25(OH)D3 concentrations, affecting their initial capacity to control pathogens [28], [36]. Currently, experimental studies specifying optimal 25(OH)D3 concentrations for an adequate immune response to infectious agents are lacking.

The present study was carried out in a herd of dairy cattle with natural exposure to M. bovis and a bTB prevalence of greater than 20% as demonstrated by the presence of DNA in nasal fluids from both negative and positive reactors to the Single Intradermal Tuberculin (SIT) test. This indicates exposure to mycobacteria, active transmission, and a high probability of becoming infected. When diagnosing bTB by SIT, only 20–30% of the cows were positive, while the rest remained negative. In this herd, bTB management consisted in separating the SIT (+) cows in an adjoining barn, with a fence as the sole division between both structures. Both groups were kept in dairy production with the same diet and husbandry practices, and the same caretakers worked in both barns. To complement the study, animals from a Holstein Friesian bTB-free herd were included. The goal of this experiment was to evaluate a possible association between serum 25(OH)D3 concentrations and a negative or positive result for bTB on a tuberculin test and an IFN-γ release assay in a herd with high natural exposure to M. bovis. In addition, the mycobactericidal activity of bovine macrophages was assessed in vitro in cultures supplemented with serum from SIT (+) or SIT (-) cows with different 25(OH)D3 concentrations.

Section snippets

Animals

Animal procedures were carried out in accordance with regulations on the use of research animals established by the School of Veterinary Medicine and Animal Science (FMVZ) of the National Autonomous University of Mexico (UNAM). This study analyzed 34 Holstein Friesian cows from tuberculosis-positive herds in Mexico with a history of positive M. bovis culture. Animals were selected randomly, with a total of 17 SIT (+) cows and 17 SIT (-) cows. Both bTB status and natural field exposure to

3.1. Consistency between single intradermal tuberculin test vs. IFN-ɣ release assay in the diagnosis of bTB and confirmation of natural exposure to M. bovis

Cattle from this study were randomly selected based on the SIT test (+ or -), which was confirmed by an IFN-ɣ release assay against mycobacterial antigens (Bovigam). Correspondence was found between the two tests (P < 0.05). All SIT (+) and (-) bovines were shown to have the same result on the IFN-ɣ release assay using bovine PPD. One SIT (-) and three SIT (+) bovines were also positive with avian PPD. There is adequate consistency between both tests, with a co-positivity and co-negativity of

Discussion

Both prevention and control of bTB require a cross-sectoral and multidisciplinary approach, linking animal, human, and environmental health [43]. In the context of One Health, the bovine model facilitates disease study and provides insight into essential aspects of the immune response involved in mycobacterial control, thus allowing for a comprehensive approach to the challenges we face at the animal–human interface [32], [44].

Several studies have demonstrated the importance of vitamins and

Funding

This study was funded by the Support Program for Research Projects and Technological Innovation (PAPIIT-UNAM IN-220615), Mexico: "Evaluation of the immunomodulatory effect of vitamin D on the viability of Mycobacterium bovis in bovine macrophages". SLC was awarded with CONACYT, Mexico graduate scholarship. EAS was supported by a sabbatical from the DGAPA-Universidad Nacional Autónoma de México, Mexico.

CRediT authorship contribution statement

Edgar Alfonseca-Silva: Conceptualization, Methodology, Investigation, Writing – original draft preparation, Visualization, Funding acquisition. Sofía López-Constantino: Conceptualization, Methodology, Investigation, Writing – original draft preparation, Visualization. Evaristo A. Barragan: Visualization Formal analysis.

Declaration of Competing Interest

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

References (70)

  • U.S. Sorge et al.

    Cow-level association between serum 25-hydroxyvitamin D concentration and Mycobacterium avium subspecies paratuberculosis antibody seropositivity: a pilot study

    J. Dairy Sci.

    (2013)
  • J.R. Stabel et al.

    Short communication: Vitamin D status and responses in dairy cows naturally infected with Mycobacterium avium ssp. paratuberculosis

    J. Dairy Sci.

    (2019)
  • S. Sato et al.

    The relationship between 25-hydroxyvitamin D levels and treatment course of pulmonary tuberculosis

    Respir. Investig.

    (2012)
  • C.D. Nelson et al.

    Vitamin D status of dairy cattle: outcomes of current practices in the dairy industry

    J. Dairy Sci.

    (2016)
  • V. Dimitrov et al.

    Species-specific regulation of innate immunity by vitamin D signaling

    J. Steroid Biochem. Mol. Biol.

    (2016)
  • W. Nouari et al.

    Vitamin D3 enhances bactericidal activity of macrophage against Pseudomonas aeruginosa

    Int. Immunopharmacol.

    (2016)
  • E. Casas et al.

    Seasonal variation in vitamin D status of beef cattle reared in the central United States

    Domest. Anim. Endocrinol.

    (2015)
  • S.M. Jeon et al.

    Exploring vitamin D metabolism and function in cancer

    Exp. Mol. Med.

    (2018)
  • E. Gormley et al.

    Pathogenesis of Mycobacterium bovis Infection: the Badger model as a paradigm for understanding tuberculosis in animals

    Front. Vet. Sci.

    (2018)
  • W.R. Waters et al.

    Mycobacterium bovis infection of cattle and white-tailed deer: translational research of relevance to human tuberculosis

    ILAR J.

    (2015)
  • E.F. Ejeh et al.

    Prevalence and direct economic losses from bovine tuberculosis in Makurdi, Nigeria

    Vet. Med. Int.

    (2014)
  • R.A. McDonald

    Animal health: How to control bovine tuberculosis

    Nature

    (2014)
  • A.W. Norman

    From vitamin D to hormone D: Fundamentals of the vitamin D endocrine system essential for good health

    Am. J. Clin. Nutr

    (2008)
  • A. Ströhle et al.

    Micronutrients at the interface between inflammation and infection - ascorbic acid and calciferol. part 1: General overview with a focus on ascorbic acid

    Inflamm. Allergy Drug Targets

    (2011)
  • J.S. Adams et al.

    Update in vitamin D

    J. Clin. Endocrinol. Metab.

    (2010)
  • E.K. Jo

    Innate immunity to mycobacteria: vitamin D and autophagy

    Cell. Microbiol.

    (2010)
  • M. Di Rosa et al.

    Vitamin D3: a helpful immuno-modulator

    Immunology

    (2011)
  • J. Bacchetta et al.

    Antibacterial responses by peritoneal macrophages are enhanced following vitamin D supplementation

    PLoS One

    (2014)
  • E.W. Kim et al.

    Vitamin D status contributes to the antimicrobial activity of macrophages against Mycobacterium leprae

    PLoS Negl. Trop. Dis.

    (2018)
  • T.P. Staeva-Vieira et al.

    1,25-dihydroxyvitamin D 3 inhibits IFN-γ and IL-4 levels during in vitro polarization of primary murine CD4 + T cells

    J. Immunol.

    (2002)
  • H. Zhang et al.

    1,25-dihydroxyvitamin D3 regulates the development of chronic colitis by modulating both T helper (Th)1 and Th17 activation

    Apmis

    (2015)
  • A.R. Martineau

    Old wine in new bottles: vitamin D in the treatment and prevention of tuberculosis

    Proc. Nutr. Soc.

    (2012)
  • B. Prietl et al.

    Vitamin D and immune function

    Nutrients

    (2013)
  • R.F. Chun et al.

    Immunomodulation by vitamin D: implications for TB

    Expert Rev. Clin. Pharmacol.

    (2011)
  • A.K. Coussens et al.

    Anti-inflammatory and antimicrobial actions of vitamin D in combating TB/HIV

    Scientifica

    (2014)
  • Cited by (0)

    View full text